Best Practice & Research Clinical Haematology
Volume 20, Issue 2 , Pages 219-229 , June 2007

Risk assessment in haematopoietic stem cell transplantation: Impact of donor–recipient sex combination in allogeneic transplantation

  • Gösta Gahrton, MD (Professor of Medicine)

      Affiliations

    • Corresponding Author InformationTel.: +46 8 58582439/+46 70 6655284; Fax: +46 8 7748725.

References 

  1. Storb R, Prentice RL, Thomas ED. Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival. The Journal of Clinical Investigation. 1977;59:625–632
  2. Eichwald EJ, Silmser CR. Skin. Transplantation Bulletin. 1955;2:148–149
  3. Goulmy E, Termijtelen A, Bradley BA, et al. Alloimmunity to human H-Y. Lancet. 1976;2:1206
  4. Zwaan F, Gratwohl A, Hermans J. The influence of donor-recipient sex mismatchingon on the outcome of allogeneic BMT in leukaemias. Bone Marrow Transplantation. 1989;4:8
  5. Gratwohl A, Hermans J, Goldman JM, et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet. 1998;352:1087–1092
  6. Randolph SS, Gooley TA, Warren EH, et al. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood. 2004;103:347–352
  7. Gahrton G, Iacobelli S, Apperley J, et al. The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow Transplantation. 2005;35:609–617
  8. Stern M, Passweg J, Locasciulli A, et al. Influence of Donor/Recipient Sex Matching on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia. Transplantation. 2006;82:218–226
  9. Spierings E, Vermeulen CJ, Vogt MH, et al. Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet. 2003;362:610–615
  10. Weisdorf D, Hakke R, Blazar B, et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation. 1991;51:1197–1203
  11. Carlens S, Ringden O, Aschan J, et al. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination. Clinical Transplantation. 1998;12:84–92
  12. Gratwohl AHJ, Niederwieser D, van Biezen A, et al. Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. The Hematology Journal. 2001;2:363–370
  13. Gratwohl A, Brand R, Apperley J, et al. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood. 2002;100:3877–3886
  14. Frassoni F, Labopin M, Gluckman E, et al. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time–a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Bone Marrow Transplantation. 1996;17:13–18
  15. Kollman C, Howe CW, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98:2043–2051
  16. Verdijk RM, Kloosterman A, Pool J, et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood. 2004;103:1961–1964
  17. James E, Chai JG, Dewchand H, et al. Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans. Blood. 2003;102:388–393
  18. Storb R, Prentice RL, Thomas ED. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. The New England Journal of Medicine. 1977;296:61–66
  19. Sanfey H. Gender-specific issues in liver and kidney failure and transplantation: a review. Journal of Women's Health. 2005;14:617–626
  20. Candinas D, Gunson BK, Nightingale P, et al. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet. 1995;346:1117–1121
  21. Rustgi VK, Marino G, Halpern MT, et al. Role of gender and race mismatch and graft failure in patients undergoing liver transplantation. Liver Transplantation. 2002;8:514–518
  22. Zeier M, Dohler B, Opelz G, et al. The effect of donor gender on graft survival. Journal of the American Society of Nephrology. 2002;13:2570–2576
  23. Neugarten J, Silbiger SR. The impact of gender on renal transplantation. Transplantation. 1994;58:1145–1152
  24. Weiden PL, Sullivan KM, Flournoy N, et al. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. The New England Journal of Medicine. 1981;304:1529–1533
  25. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990;75:555–562
  26. Kolb HJ, Schattenberg A, Goldman JM, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood. 1995;86:2041–2050
  27. Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood. 1998;91:756–763
  28. McSweeney PA, Niederwieser D, Shizuru JA, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood. 2001;97:3390–3400
  29. Niederwieser D, Maris M, Shizuru JA, et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood. 2003;101:1620–1629
  30. Crawley C, Iacobelli I, Björkstrand B, et al. Reduced-intensity conditioning does not improve survival compared to standard conditioning for patients with myeloma. Bone Marrow Transplantation. 2005;35:S48
  31. Bonnet D, Warren EH, Greenberg PD, et al. CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells. Proceedings of the National Academy of Sciences of the USA. 1999;96:8639–8644
  32. Warren EH, Gavin MA, Simpson E, et al. The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. Journal of Immunology. 2000;164:2807–2814
  33. Wang W, Meadows LR, den Haan JM, et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science. 1995;269:1588–1590
  34. Meadows L, Wang W, den Haan JM, et al. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity. 1997;6:273–281
  35. Vogt MH, de Paus RA, Voogt PJ, et al. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood. 2000;95:1100–1105
  36. Vogt MH, Goulmy E, Kloosterboer FM, et al. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood. 2000;96:3126–3132
  37. Vogt MH, van den Muijsenberg JW, Goulmy E, et al. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood. 2002;99:3027–3032

PII: S1521-6926(06)00067-3

doi: 10.1016/j.beha.2006.09.007

Best Practice & Research Clinical Haematology
Volume 20, Issue 2 , Pages 219-229 , June 2007